603590.SS

Beijing Konruns Pharmaceutical Co.,Ltd. [603590.SS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

603590.SS Stock Summary

Top 10 Correlated ETFs

603590.SS

Top 10 Correlated Stocks

603590.SS

In the News

603590.SS Financial details

Company Rating
-
Market Cap
4.5B
Income
158M
Revenue
998.77M
Book val./share
-
Cash/share
-
Dividend
0.2
Dividend %
0.57%
Employees
449
Optionable
No
Shortable
Yes
Earnings
08 Apr 2024
P/E
34.47
Forward P/E
-
PEG
46.35
P/S
5.62
P/B
1.74
P/C
-
P/FCF
56.87
Quick Ratio
4.01
Current Ratio
5.07
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.01
EPS next Y
-
EPS next Q
-
EPS this Y
-30.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-19.97%
Revenue last 5Y
-3.25%
Revenue Q/Q
-5.78%
EPS Q/Q
-16.28%
-
-
-
-
SMA20
22.51%
SMA50
24.35%
SMA100
18.94%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
5%
ROC
0.06%
Gross Margin
89%
Oper. Margin
20%
Profit Margin
16%
Payout
21%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
23.19-41.95
52W High
-25.2%
52W Low
+33.35%
RSI
65.59
Rel Volume
0.87
Avg Volume
1.76M
Volume
1.53M
Perf Week
3.34%
Perf Month
26.11%
Perf Quarter
31.35%
Perf Half Y
23.52%
-
-
-
-
Beta
0.347
-
-
Volatility
0.71%, 2.67%
Prev Close
0.23%
Price
30.67
Change
1.39%

603590.SS Financial Performance

603590.SS Dividend History

603590.SS Frequently Asked Questions

What is Beijing Konruns Pharmaceutical Co.,Ltd. stock symbol ?

Beijing Konruns Pharmaceutical Co.,Ltd. is a CN stock and trading under the symbol 603590.SS

What is Beijing Konruns Pharmaceutical Co.,Ltd. stock quote today ?

Beijing Konruns Pharmaceutical Co.,Ltd. stock price is $30.67 today.

Is Beijing Konruns Pharmaceutical Co.,Ltd. stock public?

Yes, Beijing Konruns Pharmaceutical Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
FB2A.DE
VTI
APC.DE
ABEA.DE
LLY
Top Correlated ETFs
IGOV
FXC
ISHG
UDN
ULE
Top Correlated Stocks
605009.SS
603630.SS
EONGY
NGVC
3034.T
Similar Market Cap
600198.SS
JSGRY
KPLUY
002301.SZ
600207.SS

Company Profile

Healthcare Biotechnology
  • Volume Average 1.76M
  • Market Capitalization 4.5B
  • Employee 449
  • CEO Mr. Jianhua Liu
  • Headquarters Beijing,CN
  • IPO Date 2018-09-03
  • Website https://www.konruns.cn

Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research, production, and sale of various drugs in China. The company offers Su Ling product in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery. It also engages in the development of drug candidates, including CX1026, CX1003, and KC1036. The company was founded in 2003 and is headquartered in Beijing, China.